DrugPatentWatch Database Preview
Celltrion Company Profile
What is the competitive landscape for CELLTRION, and what generic and branded alternatives to CELLTRION drugs are available?
CELLTRION has sixteen approved drugs.
Summary for Celltrion
| US Patents: | 0 |
| Tradenames: | 15 |
| Ingredients: | 15 |
| NDAs: | 16 |
| Patent Litigation for Celltrion: | See patent lawsuits for Celltrion |
| PTAB Cases with Celltrion as petitioner: | See PTAB cases with Celltrion as petitioner |
Drugs and US Patents for Celltrion
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Celltrion | RIZATRIPTAN BENZOATE | rizatriptan benzoate | TABLET;ORAL | 077526-001 | Mar 26, 2013 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Celltrion | ROPINIROLE HYDROCHLORIDE | ropinirole hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 091395-001 | Aug 27, 2012 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Celltrion | DIVALPROEX SODIUM | divalproex sodium | TABLET, DELAYED RELEASE;ORAL | 077296-002 | Jul 31, 2008 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Celltrion | RISPERIDONE | risperidone | TABLET;ORAL | 078871-001 | Oct 9, 2008 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
